<DOC>
	<DOCNO>NCT02106806</DOCNO>
	<brief_summary>Objective : To determine oxidative stress cycle chemotherapy patient surgery colorectal cancer , without oral zinc supplementation . Subjects : Twenty four adult gender participate study . All patient underwent stage II , III IV colorectal cancer surgical resection start chemotherapy HCFMRP- USP . Patients randomize two group . The first one ( QTx-Zn Group , n=10 ) receive 70 mg/d zinc orally second one receive placebo ( QTx-Placebo Group , n=14 ) 16 week . The study also include 30 healthy volunteer match age , gender socioeconomic status , receive 70 mg/d zinc supplement ( Control-Zn Group , n=21 ) placebo ( Control-Placebo Group , n=9 ) 16 week . Methods : The questionnaire dietary intake ( semiquantitative food frequency food record ) , fatigue quality life ( FACIT-F ) questionnaires assess side effect chemotherapy ( CTCAE ) evaluate . Anthropometry bioelectrical impedance measurement make . Blood collection perform 1st , 2nd , 3rd 4th cycle chemotherapy ( median duration 21 day among cicles ) . Routine laboratory test , vitamin E marker anti pro-oxidants ( MDA , SOD , GPx isoprostane ) ere determine . The control group underwent procedure , except chemotherapy . A longitudinal linear mixed effect model adjust variable interest . The model fit use PROC MIXED SAS version 9 ( SAS , CARY , NC , USA ) . To analyze association categorical variable different item CTCAE , investigator use Fisher exact test . Results : The oral zinc supplementation sufficient increase plasma level zinc alter food intake , body composition routine laboratory evaluation patient undergo chemotherapy colorectal cancer . Compared QTx-Placebo Group , QTx-Zn Group show low prevalence complaint salivary gland ( 17 vs. 75 % ) . Fatigue ( 43 ± 6 vs. 36 ± 13 ) quality life ( 126 ± 160 vs. 116 ± 27 ) become bad period 1st 4th cycle QTx QTx-Placebo Group . When compare QTx-Placebo Group , QTx-Zn Group high value SOD 1st ( 2297 ± 503 vs. 1604 ± 352 USOD/g Hb ) , 2nd ( 2037 ± 515 vs. 1712 ± 417 USOD/g Hb ) 4th ( 2202 ± 323 vs. 1821 ± 360 USOD/g Hb ) cycle QTx . GPx value decrease QTx-Zn Group 3rd cycle QTx ( 48.5 ± 7.0 vs. 54.3 ± 2.3 mol NADPH/min/gHb ) . Conclusions : These data suggest zinc supplementation reduces complaint related change salivary gland , preserve quality life prevent worsen fatigue . The increase SOD attribute zinc supplementation per se , whereas mineral cofactor endogenous antioxidant enzyme . The high activity SOD increase production H2O2 , whose detoxification involve participation GPx , justify reduction . There change plasma level vitamin E , MDA isoprostane study period . Considering value MDA isoprostane , data indicate regardless zinc supplementation , lipid peroxidation cell membrane unchanged chemotherapy .</brief_summary>
	<brief_title>Zinc Supplementation Markers Oxidative Stress Post Operative Colorectal Cancer During Chemotherapy Cycles</brief_title>
	<detailed_description>Objective : To determine oxidative stress cycle chemotherapy patient surgery colorectal cancer , without oral zinc supplementation . Subjects : Twenty four adult gender participate study . All patient underwent stage II , III IV colorectal cancer surgical resection start chemotherapy HCFMRP- USP . Patients randomize two group . The first one ( QTx-Zn Group , n=10 ) receive 70 mg/d zinc orally second one receive placebo ( QTx-Placebo Group , n=14 ) 16 week . The study also include 30 healthy volunteer match age , gender socioeconomic status , receive 70 mg/d zinc supplement ( Control-Zn Group , n=21 ) placebo ( Control-Placebo Group , n=9 ) 16 week . Methods : The questionnaire dietary intake ( semiquantitative food frequency food record ) , fatigue quality life ( FACIT-F ) questionnaires assess side effect chemotherapy ( CTCAE ) evaluate . Anthropometry bioelectrical impedance measurement make . Blood collection perform 1st , 2nd , 3rd 4th cycle chemotherapy ( median duration 21 day among cicles ) . Routine laboratory test , vitamin E marker anti pro-oxidants ( MDA , SOD , GPx isoprostane ) ere determine . The control group underwent procedure , except chemotherapy . A longitudinal linear mixed effect model adjust variable interest . The model fit use PROC MIXED SAS version 9 ( SAS , CARY , NC , USA ) . To analyze association categorical variable different item CTCAE , investigator use Fisher exact test . Results : The oral zinc supplementation sufficient increase plasma level zinc alter food intake , body composition routine laboratory evaluation patient undergo chemotherapy colorectal cancer . Compared QTx-Placebo Group , QTx-Zn Group show low prevalence complaint salivary gland ( 17 vs. 75 % ) . Fatigue ( 43 ± 6 vs. 36 ± 13 ) quality life ( 126 ± 160 vs. 116 ± 27 ) become bad period 1st 4th cycle QTx QTx-Placebo Group . When compare QTx-Placebo Group , QTx-Zn Group high value SOD 1st ( 2297 ± 503 vs. 1604 ± 352 USOD/g Hb ) , 2nd ( 2037 ± 515 vs. 1712 ± 417 USOD/g Hb ) 4th ( 2202 ± 323 vs. 1821 ± 360 USOD/g Hb ) cycle QTx . GPx value decrease QTx-Zn Group 3rd cycle QTx ( 48.5 ± 7.0 vs. 54.3 ± 2.3 mol NADPH/min/gHb ) . Conclusions : These data suggest zinc supplementation reduces complaint related change salivary gland , preserve quality life prevent worsen fatigue . The increase SOD attribute zinc supplementation per se , whereas mineral cofactor endogenous antioxidant enzyme . The high activity SOD increase production H2O2 , whose detoxification involve participation GPx , justify reduction . There change plasma level vitamin E , MDA isoprostane study period . Considering value MDA isoprostane , data indicate regardless zinc supplementation , lipid peroxidation cell membrane unchanged chemotherapy .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Zinc</mesh_term>
	<mesh_term>Zinc Sulfate</mesh_term>
	<criteria>colon rectum adenocarcinoma stage II , III , IV liver , kidney , chronic inflammatory autoimmune disease ; active infectious disease ; undergo therapy immunosuppressant ; use vitamin mineral supplementation ; chemo radiotherapy previous twelve month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Oxidative stress</keyword>
	<keyword>Zinc</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Colorectal cancer</keyword>
</DOC>